Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.70 Mn | 1.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.59% |
| Sep 30, 2025 | 53.22% |
| Jun 30, 2025 | 59.05% |
| Mar 31, 2025 | 34.35% |
| Dec 31, 2024 | 47.04% |
| Sep 30, 2024 | 34.66% |
| Jun 30, 2024 | 41.97% |
| Mar 31, 2024 | 45.39% |
| Dec 31, 2023 | 30.28% |
| Sep 30, 2023 | 50.74% |
| Jun 30, 2023 | 32.83% |
| Mar 31, 2023 | 28.32% |
| Dec 31, 2022 | 46.64% |
| Sep 30, 2022 | 15.87% |
| Jun 30, 2022 | 12.20% |
| Mar 31, 2022 | 3.07% |
| Dec 31, 2021 | 17.00% |
| Sep 30, 2021 | 29.83% |
| Jun 30, 2021 | -7.20% |
| Mar 31, 2021 | -40.28% |